Modality and dosing of acute renal replacement therapy

Minerva Urologica e Nefrologica

Volumn 68, Issue 1, 2016, Pages 78-86

  Ricci, Zaccaria ^a   Romagnoli, Stefano ^b,c   Villa, Gianluca ^b   Ronco, Claudio ^d  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c AO Universitaria Careggi   (Italy)

^d SAN BORTOLO HOSPITAL   (Italy)

Author keywords

Critical illness; Dialysis; Hemodiafiltration; Hemofiltration; Renal replacement therapy

Indexed keywords

DIALYSIS FLUID;

ACUTE KIDNEY FAILURE; ACUTE RENAL REPLACEMENT THERAPY; ANTICOAGULATION; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CONTINUOUS RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENT; HEMODIALYSIS; HEMOFILTRATION; HOSPITAL MORTALITY; HUMAN; HYPERVOLEMIA; PHARMACOLOGICAL PARAMETERS; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; REVIEW; SLOW CONTINU ULTRAFILTRATION; ULTRAFILTRATION; VOLUME OF DISTRIBUTION; ACUTE KIDNEY INJURY; BODY MASS; CRITICAL ILLNESS; HEMODIAFILTRATION; PROCEDURES; TREATMENT OUTCOME;

ACUTE KIDNEY INJURY; BODY MASS INDEX; CRITICAL ILLNESS; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME;

EID: 84975769815     PISSN: 03932249     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, et al. Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005;294:813-8.
2. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, et al. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B. E. S. T. kidney) investigators. Int Care Med 2007;33:1563-70.
3. Davenport A, Will E, Davidson A. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993;21:328-38.
4. Uchino, S., Bellomo, R., Ronco, C. Intermittent versus continuous renal replacement therapy in the ICU: impact on electrolyte and acid-base balance. Intensive Care Med 2001;27:1037-43.
5. Swartz RD, Messana JM, Orzol S, Port FK. Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 1999;34:424-32.
6. Ricci, Z., Bellomo, R. and Ronco, C. Dose of Dialysis in Acute Renal Failure. Clin J Am Soc Nephrol 2006;1:380-8.
7. Ronco C, Brendolan A, Crepaldi C, Dissegna D, Gastaldon F, Ghezzi PM, et al. Measurement of effective delivery of the prescribed dialysis treatment. Nephrol Dial Transplant 2006;11:68-74.
8. Ricci Z, Salvatori G, Bonello M, Pisitkun T, Bolgan I, D'Amico G, et al. In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care 2005;9:R266-73.
9. Ronco C, Bellomo R, Hornel P, Brendolan A, Dan M, Piccinni P, La Greca G. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000;356:26-30.
10. RENAL Replacement Therapy Study Investigators. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009;361:1627-38.
11. VA/NIH Acute Renal Failure Trial Network. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008;359:7-20.
12. Ricci Z, Ronco C. Timing, dose and mode of dialysis in acute kidney injury. Curr Opin Crit Care 2011;17:556-61.
13. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group 2012. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2012;1-138.
14. Rimmelé T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care 2011;15:205.
15. Vaara ST, Reinikainen M, Wald R, Bagshaw SM, Pettilä V; FINN AKI Study Group. Timing of RRT based on the presence of conventional indications. Clin J Am Soc Nephrol 2014;9:1577-85.
16. Ricci Z, Ronco C. Renal replacement therapy in the critically ill: getting it right. Curr Opin Crit Care 2012;18:607-12.
17. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, et al. An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med 2012;40:1753-60.
18. Claure-Del Granado R, Macedo E, Soroko S, Kim Y, Chertow GM, Himmelfarb J, et al. Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD). Hemodial Int 2014;18:641-9.
19. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH. Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999;10:846-53.
20. Pasko DA, Churchwell MD, Salama NN, Mueller BA. Longitudinal Hemodiafilter Performance in Modeled Continuous Renal Replacement Therapy. Blood Purif 2011;32:82-8.
21. Demirjian S, Teo BW, Guzman JA, Heyka RJ, Paganini EP, Fissell WH, et al. Hypophosphatemia during continuous hemodialysis is associated with prolonged respiratory failure in patients with acute kidney injury. Nephrol Dial Transplant 2011;26:3508-14.
22. Broman M, Carlsson O, Friberg H, Wieslander A, Godaly G. Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy. Acta Anaesthesiol Scand 2011;55:39-45.
23. Naka, T, Bellomo, R. Bench-to-bedside review: Treating acid - base abnormalities in the intensive care unit - the role of renal replacement therapy. Crit Care 2004;8:108-14.
24. Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, et al. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid - base status and phosphate supplementation needs. BMC Nephrol 2013;14:1.
25. Schneider AG, Bellomo R, Bagshaw SM, Glassford NJ, Lo S, Jun. M, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: A systematic review and meta-analysis. Int Care Med 2013;39:987-97.
26. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a metaanalysis. Crit Care Med 2008;36:610-7.
27. Rabindranath K, Adams J, Macleod a M, Muirhead N. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; CD003773.
28. Schefold JC, von Haehling S, Pschowski R, Bender T, Berkmann C, Briegel S, et al. The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit Care 2014;18:R11
29. Schneider AG, Bagshaw SM. Renal recovery after acute kidney injury: choice of initial renal replacement therapy modality still matters. Crit Care 2014;18:154.
30. Wald R, Shariff SZ, Adhikari NK, Bagshaw SM, Burns KE, Friedrich JO, et al. The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med 2014;42:868-77.
31. Sun Z, Ye H, Shen X, Chao H, Wu X, Yang J. Continuous venovenous hemofiltration versus extended daily hemofiltration in patients with septic acute kidney injury: a retrospective cohort study. Crit Care 2014;18:R70.
32. Matthys E, Patton M, Osgood R, Venkatachalam M, Stein J. Alterations in vascular function and morphology in acute ischemic renal failure. Kidney Int 1983;23:717-24.
33. Palevsky P, Zhang J, O'Connor T, Chertow G, Crowley S, Choudhury D, et al. Intensity of renal support in critically ill patients with acute kidney injury. World Health 2008;359:7-20.
34. Ronco C, Bellomo R, Kellum J. Critical care nephrology. In: Ronco C, Bellomo R, Kellum J, editors. Critical care nephrology. Second Edition. Philadelphia: Elsevier; 2009.
35. Kielstein JT, Kretschmer U, Ernst T, Hafer C, Bahr MJ, Haller H, et al. Efficacy and cardiovascular tolerability of extended dialysis in critically ill patients: a randomized controlled study. Am J Kidney Dis 2004;43:342-9.
36. Schwenger V, Weigand MA, Hoffmann O, Dikow R, Kihm LP, Seckinger J, et al. Sustained low efficiency dialysis using a single-pass batch system in acute kidney injury - a randomized interventional trial: the REnal Replacement Therapy Study in Intensive Care Unit PatiEnts. Crit Care 2012;16:R140.
37. Thongprayoon C, Cheungpasitporn W, Ahmed A. Trends in the use of renal replacement therapy modality in intensive care unit: a 7 year study. Ren Fail 2015;3:1-4.
38. Marshall JC, Foster D, Vincent J-L, Cook DJ, Cohen J, Dellinger RP, et al. Diagnostic and prognostic implications of endotoxemia in critical illness: results of the MEDIC study. J Infect Dis 2004;190:527-34.
39. Cruz DN, Antonelli M, Fumagalli R, Foltran F. Early use of polymyxin b hemoperfusion in abdominal septic shock. JAMA 2009;301:2445-52.
40. Payen DM, Guilhot J, Launey Y, Lukaszewicz AC, Kaaki M, Veber B, et al. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Int Care Med 2015;41:975-84.
41. Klein DJ, Foster D, Schorr C, Kazempour K, Walker PM, Dellinger RP. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. Trials 2014;15:218.
42. Lonneman G. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int 1999;56:S84-7.
43. Borthwick E, Hill C, Rabindranath K, Maxwell A, Mcauley D, Blackwood B. High-volume haemofiltration for sepsis. Cochrane Database Syst Rev 2013;31:CD008075.
44. Joannes-Boyau O, Honoré PM, Perez P, Bagshaw SM, Grand H, Canivet JL, et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Int Care Med 2013;39:1535-46.
45. Villa G, Chelazzi C, Valente S, De Gaudi A, Romagnoli S. Hemodialysis with high cutoff membranes improves tissue perfusion in severe sepsis: preliminary data of the Sepsis in Florence sTudy (SIFT). Critical Care 2014;18(Suppl 1):401.
46. Villa G, Zaragoza JJ, Sharma A, Neri M, De Gaudio R, Ronco C. Cytokine Removal with High Cut-Off Membrane: Review of Literature. Blood Purification 2014;38:167-73.
47. Hotchkiss RS, Monneret G, Payen D. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy. Nature reviews Immunology. Nature Publishing Group; 2013;13:862-74.
48. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, et al. A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 2002;30:1250-5.
49. Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M, et al. Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Int Care Med 2003;29:703-8.
50. Bellomo R, Tetta C, Ronco C. Coupled plasma filtration adsorption. Int Care Med 2003;29:1222-8.